KALA BIO宣布CHASE 2B期临床试验顶线结果:评估KPI-012治疗持续性角膜上皮缺陷未达主要终点
KALA BIO宣布CHASE 2B期临床试验顶线结果:评估KPI-012治疗持续性角膜上皮缺陷未达主要终点
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.